By statute (NRS 422.4025), the State of
Nevada requires the DHCFP to develop and maintain a Preferred Drug List (PDL)
to be used for the Medicaid program and CHIP, and each public or nonprofit
health benefit plan that elects to use the PDL. The Silver State Scripts Board
(formerly known as the Pharmacy & Therapeutics or P&T Committee) was
established to identify prescription drugs to be included on the PDL.
A governing body of a county, school
district, municipal corporation, political subdivision, public corporation or
other local government agency of the State of Nevada that provides coverage of
prescription drugs pursuant to NRS 287.010 or any issuer of a policy health
insurance purchased pursuant to NRS 287.010 may use the PDL developed by DHHS
as its PDL.
The PDL is not a restricted formulary.
Drugs not on the PDL are still available to recipients if they meet the
Standard Preferred Drug List Exception criteria.
The Silver State Scripts Board consists of
members who are Director-appointed physicians and pharmacists. Members must be
licensed to practice in the State of Nevada as either an actively practicing
physician or an actively practicing pharmacist.
Meetings are held quarterly and are open to
the public. Anyone wishing to address the Silver State Scripts Board may do so.
Public comment is limited to 5 minutes per speaker/organization (due to time
constraints). Anyone presenting documents for consideration must provide
sufficient copies for each Board member and an electronic copy to the DHCFP
Coordinator for official record.
For pharmacists and physicians wishing to
serve on the Silver State Scripts Board, please email your contact information,
NPI and current CV/Resume to email@example.com